ALICON NSI Week ended 07 Aug 2026

Weekly Investor Report

Alicon Castalloy Limited · Industrials · Metal Fabrication

Open interactive chart View report data
Latest close 742.8 INR
11.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 9.2% above the Trend Line and sits at 37.3% of its 52-week range. The latest completed week returned 11.5%, after a 17.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100.

Setup score 57 out of 100
Latest Close 742.8 INR 7 Aug 2026
1W Return 11.5% latest completed week
4W Return 17.4% short-term follow-through
12W Return 13.1% quarterly tape
Trend Breadth 30.8% 16 of 52 weeks active
Volume Ratio 5.2x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 11.5% Latest completed week; four-week move 17.4%. Indicator stack 17/91 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Buy Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 16 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 9.2% above the Trend Line and sits at 37.3% of its 52-week range. The latest completed week returned 11.5%, after a 17.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 5.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 17.4% over four weeks, 13.1% over 12 weeks, and -8.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W11.5%
4W17.4%
12W13.1%
26W3.6%
52W-8.8%
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.65Latest activity-pressure read.
Pressure change361.2%Four-week change in activity pressure.
Leadership-0.64Latest relative-leadership reading.
RS change96.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength84/100Blend of value, momentum, and quality. Underlying universe rank 17; rank 1 is best.
Value89/100Relative valuation strength. Underlying universe rank 12; rank 1 is best.
Quality63/100Profitability and accounting quality. Underlying universe rank 38; rank 1 is best.
Momentum27/100Medium-term price momentum. Underlying universe rank 74; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework57/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
35.2x
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
8.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
46.7%
Gross profit retained from each unit of revenue.
Operating margin
5.1%
Operating profit retained from revenue.
Free-cash-flow margin
5.2%
Free cash flow generated from revenue.
Return on invested capital
7.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
3.2%
Latest one-year revenue growth.
EPS growth
-25.6%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
317.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.7%
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
0.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 16 relevant articles.

1 positive · 14 neutral · 1 negative
Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-27.1%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+11.5%Week of 7 Aug.
Worst week-11.8%Week of 15 May.
Latest week+11.5%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks0
Modest losses8
Sharp losses4
Recent vol5.1%13-week weekly-return volatility.
Base vol4.4%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape49/100

Trend, activity pressure, participation, and risk combine to a 49/100 tape read.

 Indicator analysis26/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.10; No reversal markers Factors66/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 68; Small Cap Core rank 15 SVQF57/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 683.5 of 1576 Patient CapitalFresh

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Fresh buy signal Sentiment50/100

Weighted news tone is neutral across 16 relevant articles.

Board of Alicon Castalloy approves capex of Rs 125 cr for setting up new plant Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026742.8 INR11.5%680.3 INR896.6 INR0.65-0.64374.3KOff
31 Jul 2026666.2 INR4.7%681.8 INR897.0 INR0.24-10.3890.3KOff
24 Jul 2026636.3 INR0.5%687.7 INR898.2 INR0.07-12.6774.3KOff
17 Jul 2026633.5 INR0.1%694.5 INR899.3 INR0.09-15.6337.3KOff
10 Jul 2026632.5 INR-2.8%700.9 INR900.5 INR0.14-15.8957.0KOff
3 Jul 2026650.8 INR0.9%708.4 INR901.8 INR0.05-14.3711.2KOff
26 Jun 2026645.0 INR-0.9%716.0 INR903.0 INR-0.05-14.800Off
19 Jun 2026651.2 INR1.3%724.2 INR904.0 INR-0.03-14.2312.7KOff
12 Jun 2026642.5 INR-1.4%732.5 INR904.5 INR-0.13-14.359.1KOff
5 Jun 2026651.9 INR-3.8%740.3 INR905.3 INR0.04-12.6110.6KOff
29 May 2026677.6 INR3.4%748.7 INR905.8 INR0.36-10.3070.4KOff
22 May 2026655.2 INR-0.3%757.0 INR906.2 INR0.36-14.2838.6KOff
15 May 2026657.0 INR-11.8%764.2 INR906.7 INR0.47-14.19143.1KOff
8 May 2026744.6 INR7.0%770.5 INR907.3 INR0.25-5.07107.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context